While we have previously shown that MCL1 inhibitors can have direct tumor killing activity in some human uveal melanoma cell lines [27], we did not observe any statistically significant change in the growth of B16.F10 melanoma tumors in the immunocompromised nude mice (Fig. 1A). This evidence concerns the gene MCL1 and uveal melanoma.